Events
| Tue | ||
|---|---|---|
The Online Seminar shows the Possibilities of the use of Desktop-Sharing Software. The Online-Seminar is free of charge an will contain the following topic. How to Setup the Software. The Webinar will held on request, the duration is approx. 30 Minutes Further Information to the Online-Seminar Allan Gonsher and Kids Inc are pleased to a offer a series of Play Therapy Webinars. If your work with children, or want to work with children, these are workshops that you can not afford to miss. Each webinar workshop offers one hour of continuing education credit. Start: 08/07/2012 10:00 am
Overview: This presentation will cover the contents of the guidance that was given. FDA has issued as rule that relieves Phase 1 products from complying with the GMP given in 21 CFR 211. At the same time, they ruled that the products must continue to comply with the GMP as given in the Food, Drug, and Cosmetic Act. Guidance was then given to describe these GMP. Areas Covered in the Session: Who Will Benefit: Steven S. Kuwahara, Ph.D. is the founder and Principal of GXP BioTechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals. Steve has over 30 years of experience in supervising quality control laboratories, including an animal testing facility, and in performing GLP and GMP audits of internal and external testing laboratories . Steve has participated in the development of drugs and biologicals through all phases of clinical research and final product production. Price List: Phone: 800-447-9407 webinars@globalcompliancepanel.com Start: 08/07/2012 10:00 am
End: 08/07/2012 11:30 am
Why Should You Attend: The most important area audited by the FDA is CAPA - it assures the FDA that company is in compliance without the Agency constantly auditing it. Closed-loop CAPA mandates a repeatable, systematic Failure Investigation and Root Cause Analysis - define, locate and resolve the basic problem(s) or root cause(s). A full-capture investigation, verification/validation, monitoring, change control methodology, coupled with accurate root cause analysis is crucial to a "closed-loop" CAPA system, that meets / exceeds CGMP requirements and U.S. FDA expectations. Who Will Benefit: This webinar will provide valuable assistance to all regulated companies that need a repeatable methodology / defined systems, and simple but powerful tools for "closed loop" CAPA, including proper failure investigation / root cause analysis and making the fix permanent. This applies to companies in the Medical Device, Diagnostic, Pharmaceutical, and Biologics fields. The employees who will benefit include: * Senior management Start: 08/07/2012 7:00 pm
End: 08/07/2012 8:00 pm
Unable to manage cost savings & efficiency gains those are critical to leverage in today's challenging global economy. The answer is Free Webinar ODI - For Scalable High Performance ELT Architecture Agenda: Target Audience: Free Registration: Read more: | ||
